Baddley 2008.

Study characteristics
Methods	Prospective cohort study
Participants	46, 43 people with PDH
Interventions	ITRA (dosing not stated) (32/41 participants) dAmB (22/41 participants) lAmB (7/41 participants)
Outcomes	All‐cause mortality at 3 months postdiagnosis of histoplasmosis
Age	Mean 38 (range not stated) years
Setting	USA
Disease severity	Mild to severe
Notes	All‐cause mortality at 3 months postdiagnosis of histoplasmosis was 18/46 participants. Mortality data not reported by treatment regimen.